News announcement late yesterday that Gilead will be authorizing generic Hep C medication in the US starting from early next year, but somehow the generics will still cost $24,000 USD though.

Just goes to show that no matter how much posturing occurs the focus is still clearly on profits over patients.

cen.acs.org/pharmaceuticals/Gilead-launc...-generics-two/96/i39